HDAC9 and type 2 diabetes mellitus: Conversely, treatment with a class II HDAC inhibitor (MC1568) rescues the dysfunctional insulin release of Hdac7-over-expressed β-cells and human islets from T2D donors (Daneshpajooh et al., 2018).